National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 251 cases where Vaccine is HPV or HPV2 or HPV4 and Symptom is Mental disability or Mental disorder or Mental disorder due to a general medical condition or Mental impairment or Mental retardation or Mental retardation severity unspecified or Mental status changes

Case Details

This is page 12 out of 26

Result pages: prev   3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next


VAERS ID: 526668 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Female  
Location: Foreign  
Vaccinated:2011-09-10
Onset:0000-00-00
Submitted: 2014-03-25
Entered: 2014-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Amenorrhoea, Disturbance in attention, Eating disorder, Endocrine disorder, Illusion, Malaise, Memory impairment, Mental impairment, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Dementia (broad), Psychosis and psychotic disorders (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Depression (excl suicide and self injury) (broad), Fertility disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Fever; Malaise; Pain; Swelling
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0977912A

Write-up: This case was reported by a physician via a regulatory authority (# V13001241) and described the occurrence of cerebration impaired in a 20-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 10 September 2011, the subject received 1st dose of CERVARIX (intramuscular and unknown site of injection). After the 1st dose of CERVARIX, the subject experienced pyrexia, swelling, severe pain, and malaise which persisted for 1 month. On 4 October 2011, the subject received 2nd dose of CERVARIX (intramuscular, unknown site of injection and batch number). After the second dose of CERVARIX, the subject experienced swelling and general malaise which persisted for 1 month. On 3 April 2012, the subject received 3rd dose of CERVARIX (intramuscular, unknown site of injection and batch number). After the 3rd dose of CERVARIX, swelling and general malaise were noted, which persisted for 1 month. In the summer of 2013, the subject experienced dizziness on standing up. In the fall of 2013, the subject experienced amenorrhoea (endocrine disorder). Kaufmann''s treatment was performed. The subject again experienced general malaise. In March 2014, perceptual disturbance, impaired cerebration (calculation, memory, and concentration), eating disorder and general malaise were noted. At the time of reporting, endocrine disorder and concentration impaired were unresolved. The symptoms had been progressing. The physician considered the events were clinically significant (or requiring intervention). The physician considered that endocrine disorder and concentration impaired were related to vaccination with CERVARIX.


VAERS ID: 527997 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2009-01-29
Onset:0000-00-00
Submitted: 2014-04-10
Entered: 2014-04-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Alopecia, Malaise, Mental disorder, Overdose, Pain, Polyarteritis nodosa, Suicide attempt
SMQs:, Suicide/self-injury (narrow), Interstitial lung disease (broad), Dementia (broad), Drug abuse and dependence (broad), Eosinophilic pneumonia (broad), Vasculitis (narrow), Medication errors (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: 2006, Polyarteritis nodosa
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1404DNK005807

Write-up: Information received from Sanofi Pasteur MSD (reference DK-1577272925-E2014-03016) on 08-APR-2014. Case received from consumer via patient insurance company (ref. no 13-5730) and the Health Authority on 03-APR-2014 under the reference number DK-DKMA-ADR 22453466. The primary reporter was the patient''s parent. A 14 year old female patient, had received first dose of GARDASIL (batch number not reported) via not reported route of administration in not reported site of administration on 29-Jan-2009 and later on a non-specified date in the beginning of 2009 (in connection to vaccination) she developed symptoms reoccurrence of PAN (polyarteritis nodosa). In addition, on a non-specified date, the patient developed psychological stress reactions, hair loss, pain, stretch mark and malaise. According to the reporter these reactions resulted in a severe suicide attempt with an overdoses of paracetamol (other MFR) and HJERTEMAGNYL (other MFR). The patient had no other concomitant medications. As the PAN symptoms came soon after the vaccination, the hospital visits started already in Feb-2009. The reporter states that there was a clear association with the vaccination and onset of symptoms as the patient had not developed any form of infection which could have triggered the symptoms. The physicians rejected the reporter''s suspicion. The suspicion from the parent was so strong that the patient was not allowed further vaccination than that single time. Since the flare-up in 2009, the physician have not been able to control the patient''s disease (over 4-years progression), and she is constantly investigated at the hospital. The disease itself, and the strong medications prednisolone (other MFR), MYFORTIC (other MFR), ROACTEMRA (infusion, other MFR) and NEXIUM (other MFR) (during the time at the rheumatology department in hospital) has given irreversible physical injury. In addition, psychologically it has been a major load for the patient, especially after she turned 14 years. The patient has given up on her studies and ability to work, as the disease is so painful and inhibitory for long periods. The patient has in rounds tried to start with her education, but has been forced to cancel since her absence has been too much. The patient''s medical history includes polyarteritis nodosa (unknown if continuing) which she was diagnosed with in 2006. The patient was in that context investigated at a hospital during a 3-year period, where the disease, came at rest, and the patient experienced no problems or symptoms. At the time of reporting, the outcome was not recovered for PAN, pain, disability and psychological stress reactions. The outcome was unknown for all other events.


VAERS ID: 530857 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Foreign  
Vaccinated:2012-12-19
Onset:2013-03-01
   Days after vaccination:72
Submitted: 2014-05-14
   Days after onset:438
Entered: 2014-05-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA164AA / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Asthenia, Cognitive disorder, Mental impairment, Sleep disorder, Tremor
SMQs:, Neuroleptic malignant syndrome (broad), Dementia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B0992416A

Write-up: This case was reported by a regulatory authority (V1600067) and described the occurrence of cerebration impaired in a 16-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX; GlaxoSmithKline; intramuscular; given on 19 November 2012. On 19 December 2012, the subject received 2nd dose of CERVARIX (intramuscular, unknown injection site). From March 2013, 3 months after vaccination with CERVARIX, the subject experienced weakness. Around April 2013, the subject stared to experience shaking of hands. On 01 May 2014, the subject visited medical center A for the first time where weakness, sleep disorder and cognitive decline were observed. The cerebration impaired was diagnosed. The regulatory authority reported that the event was clinically significant (or requiring intervention). At the time of reporting the event was unresolved. The regulatory authority reported that the event was related to vaccination with CERVRIX.


VAERS ID: 531726 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Unknown  
Location: Foreign  
Vaccinated:2012-11-16
Onset:2012-12-01
   Days after vaccination:15
Submitted: 2014-05-22
   Days after onset:536
Entered: 2014-05-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 9QN06R / 2 UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Activities of daily living impaired, Dyscalculia, Headache, Malaise, Memory impairment, Mental impairment, Muscular weakness, Sleep disorder
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Dementia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Depression (excl suicide and self injury) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1405JPN010964

Write-up: Initial information has been received from a physician via the regulatory agency concerning a 13 year old patient who on 16-NOV-2012 was vaccinated with GARDASIL injection drug (lot no.: 9QN06R) for the second time (dose and administration route were not reported). Information including the underlying/concomitant diseases and past medical history was not obtained. Other concomitant medications were not reported. On 14-SEP-2012, the patient was vaccinated with GARDASIL (lot no.: 9QN05R) for the first time. On 16-NOV-2012, the patient was vaccinated with GARDASIL for the second time, as stated above. From around this time, muscular weakness was noted. In around December 2012, higher brain dysfunction developed. In January 2013, the patient presented with headache and generalised malaise. In March 2013, the patient stopped attending school. On 15-MAR-2013, the patient was vaccinated with GARDASIL (lot no.: 9QN07R) for the third time. In May 2014, the patient visited the reporting physician''s hospital for the first time. Dyscalculia, memory impairment, and sleep disorder were noted. At the time of the report, higher brain dysfunction was not resolved. Reporter''s comment: Not provided. The reporting physician considered higher brain dysfunction as serious as it may result in disability. The reporting physician felt that higher brain dysfunction was related to GARDASIL and considered that there was no other causative factor. Additional information has been requested.


VAERS ID: 534025 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2011-03-28
Onset:2011-05-01
   Days after vaccination:34
Submitted: 2014-06-16
   Days after onset:1142
Entered: 2014-06-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA123AA / 2 LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Arthralgia, Asthenia, Headache, Illusion, Menstruation irregular, Mental impairment, Psychogenic seizure, Sleep disorder, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Psychosis and psychotic disorders (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Fertility disorders (broad), Hypotonic-hyporesponsive episode (broad), Arthritis (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B1003738A

Write-up: This case was reported by a physician via a regulatory authority (Agency # V14000128) and described the occurrence of cerebration impaired in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 25 February and 28 March 2011, the subject received 1st and 2nd doses of CERVARIX (intramuscular, unknown injection sites). At an unspecified date, the subject experienced arthralgia, headache, psychogenic nonepileptic seizures, weakness and syncopes, which were not reported as adverse event by the reporter. In May 2011, about 2 months after vaccination with CERVARIX, the subject experienced higher brain dysfunction. The regulatory authority reported that the event was clinically significant (or requiring intervention). On 03 September 2011, the subject received the 3rd dose of CERVARIX (intramuscular, unknown injection site and batch number: AHPVA138AC). On 24 February 2014, the event was still unresolved, and the subject visited medical center A. Perceptual disturbance, sleep disorder, menstrual irregularity, weakness and higher brain dysfunction were noted. On 09 June 2014, the outcome was unresolved. The regulatory authority reported that the event was related to vaccination with CERVARIX. Clarification has been requested.


VAERS ID: 535224 (history)  
Form: Version 1.0  
Age: 14.0  
Sex: Female  
Location: Foreign  
Vaccinated:2010-12-21
Onset:2013-09-01
   Days after vaccination:985
Submitted: 2014-06-26
   Days after onset:298
Entered: 2014-06-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA100AA / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Activities of daily living impaired, Convulsion, Hypoaesthesia, Memory impairment, Mental impairment, Muscular weakness, Sleep disorder, Wheelchair user
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Systemic lupus erythematosus (broad), Dementia (broad), Convulsions (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Depression (excl suicide and self injury) (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B1006540A

Write-up: This case was reported by a physician via a regulatory authority (Agency # V14000151) and described the occurrence of cerebration impaired in a 14-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). On 21 December 2010, the subject received 1st dose of CERVARIX (intramuscular, unknown injection site). At an unspecified time after vaccination with CERVARIX, the subject experienced numbness in fingers of left hand. On 28 January 2011, she received 2nd dose of CERVARIX (intramuscular, unknown injection site). In April 2011, the subject entered high school and joined a club with activities extremely intense. On 22 June 2011, the subject received 3rd dose of CERVARIX (intramuscular, unknown injection site). In April 2013, 22 months after vaccination with 3rd dose CERVARIX, the subject experienced numbness of left extremities. In September 2013, cerebration impaired developed. In March 2014, the subject became unable to ride a bicycle. In April 2014, weakness appeared in the right upper extremity. In June 2014, the subject experienced sleep disorder, memory impairment, psychogenic non-epileptic seizures and she needed to use a wheelchair. The regulatory authority reported that the events were clinically significant (or requiring intervention). At the time of reporting the events were unresolved. The regulatory authority reported that cerebration impaired was related to vaccination with CERVARIX.


VAERS ID: 537075 (history)  
Form: Version 1.0  
Age: 13.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-01-26
Onset:2013-01-26
   Days after vaccination:0
Submitted: 2014-07-21
   Days after onset:540
Entered: 2014-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0700AA / 3 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Anxiety, Dyspnoea, Illusion, Malaise, Menstruation irregular, Mental impairment, Psychogenic seizure, Sleep disorder
SMQs:, Anaphylactic reaction (broad), Dementia (broad), Acute central respiratory depression (broad), Psychosis and psychotic disorders (narrow), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Fertility disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1407JPN008135

Write-up: Initial information has been received from a physician via the Agency concerning a 14 year old female patient who on 29-SEP-2012 received the second vaccination with a dose of GARDASIL intramuscular injection (Lot no. 9QN04R, dose not reported). Information including underlying/concomitant diseases and medical history was not obtained. On the pre-vaccination interview form, special notes (including underlying disease, allergy, vaccination and disease during recent one month, regular medications, adverse drug reaction history and growth status) were unknown. The body weight at birth was 3296g. Other concomitant medications were not reported. On 26-JUL-2012, the patient received the first vaccination of GARDASIL (Lot no. 9QN04R) at another hospital. On 29-SEP-2012, the patient received the second vaccination of GARDASIL (Lot no. 9QN04R) at another hospital. She had general malaise. On 26-JAN-2013, the patient received the third vaccination of GARDASIL (Lot no. 9QN06R) at another hospital. Forty minutes after, the patient presented with anxiety and dyspnea. On an unspecified date, the patient developed higher brain dysfunction. In June 2014, the patient made the first visit to the reporting hospital. Perceptual disturbance, sleep disorder, memory impairment, irregular menstruation and psychogenic non-epileptic seizure were noted. As of the time of this report, the patient had not recovered from high brain dysfunction. Reporter''s comment: Not reported. The reporting physician considered higher brain dysfunction as serious due to possible disability (also reported medically significant). The reporting physician felt that higher brain dysfunction was related to GARDASIL with no other causative factor. Additional information has been requested.


VAERS ID: 539965 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Foreign  
Vaccinated:2011-03-05
Onset:2011-05-08
   Days after vaccination:64
Submitted: 2014-08-14
   Days after onset:1194
Entered: 2014-08-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Arrhythmia, Arthropathy, Asthenia, Convulsion, Diarrhoea, Dizziness, Dysmenorrhoea, Eczema, Gait disturbance, Haemodynamic instability, Headache, Hemiplegia, Hyperhidrosis, Hypoaesthesia, Loss of consciousness, Menarche, Mental impairment, Nausea, Neuropathy peripheral, Pyrexia, Sudden hearing loss, Syncope, Tachycardia, Tinnitus, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Convulsions (narrow), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Hearing impairment (narrow), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (narrow), Arthritis (broad), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B1022161A

Write-up: This case was reported by a consumer (ombudsperson) via a foreign regulatory authority and described the occurrence of loss of consciousness in a 16-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). In January 2011, the subject received information of the vaccination from the city government and also got some guidance at school. The subject decided to receive vaccination because the subject could receive the vaccine at public expense while the subject was a tenth grader. Concurrent vaccination included unspecified dose of CERVARIX (GlaxoSmithKline) given on 5 February 2011. On 5 March 2011, the subject received unspecified dose of CERVARIX (intramuscular, unknown injection site and batch number). On 6 March 2011, the subject had syncope and pyrexia after taking a bath. On 8 May 2011, 64 days after vaccination with CERVARIX, the subject experienced attack of unconsciousness while carrying instrument on stairway at school. The subject had numbness in right side of the body (peripheral neuropathy). On 10 May 2011, the subject had attack of unconsciousness and tinnitus at school. The subject had menstruation for the first time after the vaccination (dark red in colour). The subject was suffering from symptoms including loss of consciousness, sudden hearing loss, sweaty and headache until around June 2011. On 5 November 2012, the subject received influenza vaccine. On 6 November 2012, the subject had symptoms including tinnitus, pyrexia and eczema on both hands. Vomiting and diarrhoea persisted for more than 1 month. On 19 November 2012, the subject had attack of unconsciousness at school and was admitted to a general hospital for a day. On 28 November 2012, the subject had a very large amount of menstrual flow which was dark red in colour and thick. On 2 December 2012, as the menstrual flow was stopped, the subject had pitch-black haemorrhage with intensive pain immediately before the haemorrhage. On 3 December 2012, the subject had tachycardia. Subsequently, symptoms of arrhythmia, syncope, giddiness, vomiting, queasy feeling and seizure persisted. On 11 May 2013, the subject started to walk like rolling the right foot inward. On 18 June 2013, the subject had attack of unconsciousness and symptom of generalised weakness. On 19 June 2013, the subject had numbness of the right upper and lower extremities. On 21 June 2013, the subject had convulsion, difficulty in walking and drooping right shoulder. Subsequently, the subject had symptoms including clouding of consciousness, syncope, arrhythmia, tachycardia, epistaxis, menstrual irregularity, headache, especially occipital headache, giddiness, tinnitus, convulsion of right upper and lower extremities. On an unspecified date, the subject had hemiplegia, reduced thinking and hemodynamic instability. The regulatory authority reported that the events were clinically significant (or requiring intervention). From October 2013, the subject started receiving infusion treatment with PALUX and underwent rehabilitation at a hospital. In March 2014, the subject was treated with steroid pulse therapy at a hospital in a rural area. At the time of reporting, the outcome of the events was unspecified. No further information was available, therefore the case was closed.


VAERS ID: 542765 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Foreign  
Vaccinated:2013-01-01
Onset:0000-00-00
Submitted: 2014-09-05
Entered: 2014-09-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Abasia, Chelation therapy, Dizziness, Mental disorder, Neck pain, Pain in extremity, Spinal pain, Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Dementia (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: WAES1409COL000358

Write-up: This spontaneous report as received from a patients father via a social media news refers to a 18 year old female patient. On JAN-2013 the patient was vaccinated with a dose of GARDASIL, intramuscular (dose, lot number and expiration date not reported for HPV). On an unknown date the patient experienced dizziness, fainting, leg pain and walking disability for 2 months. It was also reported that patient presented pain in column and neck. On an unknown date, the patient was hospitalized without improvement of the symptoms mentioned. On an unknown date, the patient was hospitalized again without improvement of the symptoms. On an unknown date, the patient was diagnosed with issues related to psychological issues. Chelation treatment was started, due to a possibly of intoxication with heavy metals. At the time of the report the outcome of dizziness, fainting, leg pain, walking disability, column pain, neck pain and psychological issues was reported as recovering and the outcome of possible intoxication with heavy metals was unknown. Upon internal review the event of walking Disability was considered to be Disabling event. Additional information has been requested.


VAERS ID: 543657 (history)  
Form: Version 1.0  
Age: 20.0  
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2014-09-12
Entered: 2014-09-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 3 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Chronic fatigue syndrome, Feeling abnormal, Gait disturbance, Learning disorder, Malaise, Mental impairment, Muscular weakness
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Dementia (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC Split Type: B1032209A

Write-up: This case was reported in a literature article and described the occurrence of cerebration impaired in a 2 decades-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX; intramuscular given on an unspecified date. In 2010, the subject received 3rd dose of CERVARIX (intramuscular, unknown route and injection site; number not provided). In October 2013, 3 years after vaccination with CERVARIX, the subject experienced chronic fatigue syndrome. At an unspecified time after vaccination with CERVARIX, the subject experienced cerebration impaired, walking difficulty, weakness of limbs, general malaise, learning disorder and fuzzy head. The subject was hospitalised. In April 2014, the outcome of walking difficulty was improved. At the time of reporting the outcome of cerebration impaired, weakness of limbs, general malaise, learning disorder, chronic fatigue syndrome and fuzzy head was unspecified.


Result pages: prev   3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=12&SYMPTOMS[]=Mental_disability_%2810027353%29&SYMPTOMS[]=Mental_disorder_%2810061284%29&SYMPTOMS[]=Mental_disorder_due_to_a_general_medical_condition_%2810061285%29&SYMPTOMS[]=Mental_impairment_%2810027374%29&SYMPTOMS[]=Mental_retardation_%2810027378%29&SYMPTOMS[]=Mental_retardation_severity_unspecified_%2810027380%29&SYMPTOMS[]=Mental_status_changes_%2810048294%29&VAX[]=HPV&VAX[]=HPV2&VAX[]=HPV4


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166